DYAI — DYADIC INTERNATIONAL INC
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1213809 ·
Last close
$0.32
Market Cap
$12.66M
52W High
$1.60
52W Low
$0.30
ADV30
91,454
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 172,729 | -202,386 | -1,806,709 | -1,357,041 | 7,933,674 | 3,926,803 | 10,511,370 |
| Jun 2026 | 123,886 | -860,279 | -2,045,511 | -2,123,884 | 6,536,531 | 1,425,364 | 8,923,775 |
| Mar 2026 | 623,590 | -168,250 | -1,912,284 | -1,954,683 | 7,809,573 | 4,247,269 | 8,217,305 |
| Dec 2025 | 235,716 | -148,892 | -1,524,929 | -1,567,263 | 9,945,725 | 4,622,331 | 8,713,315 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,403,841
Investing CF
$1,470,913
Financing CF
$4,940,695
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.23
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-97,529,675
Inventory
—
Receivables
$1,318,453
ST Investments
$1,688,355
EBIT TTM
$-7,174,774
Pretax Income TTM
$-7,621,842
Interest Exp TTM
$447,068
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,802,237
EBITDA
—
Free Cash Flow
$-4,809,161
Enterprise Value
$13,847,801
Total Cash
$3,113,719
Total Debt
$5,046,064
Shares Out
40,063,703
Trailing EPS
$-0.23
Book Value
$0.03
ROE
-2826.9%
ROA
-63.0%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,232,311 | -7,145,916 | -7,364,628 | 9,945,725 | 8,713,315 | 1,232,410 | -5,702,221 |
| Dec 2024 | 3,495,389 | -5,878,261 | -5,809,159 | 9,930,275 | 7,459,985 | 2,470,290 | -3,974,806 |
| Dec 2023 | 2,898,806 | -8,191,322 | -6,795,461 | 8,219,236 | 2,340,651 | 5,878,585 | -6,726,755 |
| Dec 2022 | 2,930,303 | -10,115,760 | -9,735,258 | 13,712,818 | 2,625,079 | 11,087,739 | -8,083,775 |
TTM Snapshot
Revenues TTM
$3,802,237
NetIncome TTM
$-7,621,842
OpCashFlow TTM
—
Assets (Latest)
$6,536,531
Forward EPS
$-0.32
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ATYR | aTYR PHARMA INC | $12.47M | $4.99 | — |
| BCDA | BioCardia, Inc. | $11.93M | $0.79 | — |
| PASG | Passage BIO, Inc. | $13.58M | $4.22 | — |
| PLUR | Pluri Inc. | $14.09M | $0.98 | — |
| ESLA | Estrella Immunopharma, Inc. | $14.42M | $0.33 | — |
News headlines (Yahoo Finance, 1h cache)
DYAI: First Product Sales Are Modest
2026-11-16 17:02 · Yahoo
Dyadic: 3 Key Takeaways for Long-Term Investors
2026-11-13 16:42 · Yahoo
Dyadic (DYAI) Q3 2026 Earnings Call Transcript
2026-11-13 16:13 · Yahoo
Dyadic International, Inc. Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
Dyadic International Inc (DYAI) (Q3 2026) Earnings Call Highlights: Transferrin Breakthrough, ...
2026-11-13 05:02 · Yahoo
Dyadic Announces Third Quarter 2026 Financial Results and Recent Developments
2026-11-12 21:05 · Yahoo
Dyadic’s C1-Produced RSV and Malaria Antibodies Advance into Animal Studies Following Positive Independent Evaluations
2026-11-12 12:30 · Yahoo
Dyadic Applied BioSolutions, BRIG BIO and Strive Nutrition Announce a Strategic Collaboration to Accelerate the Commercialization of Precision-Fermented Alpha-Lactalbumin for Premium Nutrition Markets
2026-11-10 12:30 · Yahoo
Dyadic to Report Q3 2026 Financial Results and Host Conference Call on Thursday November 12, 2026
2026-10-30 20:05 · Yahoo
DYAI: Second Quarter Results
2026-08-14 17:02 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.